InsidersTradesSigma
Follow the Hemant Surgical stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €5bn. The latest transaction was reported on 2 June 2026 (Acquisition). Among the most active insiders: Singularity Equity Fund I. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 17,768 of 29,064 companies
45.2
score / 100
Value33
Quality58
FCF yld-6.4%
Earn yld3.4%
EV/EBITDA20.2x
ROE18%
Gross mgn23%
Net mgn7.8%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 June 2026
Declarations2 total
649,600 shares-Allotment Of Warrants On Preferential BasisSEBI:483019c40efc95d55738f475ea991c375f0d4251
Canonical exit: 31 Aug 2026 (T+90)
649,600 shares-Allotment Of Warrants On Preferential BasisSEBI:20effae52d01b0610ccb0df91f86b3731014f3cc
Canonical exit: 31 Aug 2026 (T+90)
2 of 2 declarations
关于 Hemant Surgical
Hemant Surgical 是一家在XBOM上市的公司，专门从事手术器械的制造和分销。它专注于医疗产品创新和质量。